IGF-DES 0.1mg Kit
$70.00
(IGF-1 DES CB35475644); supplier specifications (Wuhan Senwayer Century Chemical, Hubei KDG Web Science & Technology); structural analysis of Des(1-3) IGF-1 splice variants in human tissues (PMID: 12471016).
Description
🧪 Product Profile: IGF-1 DES
Product Name: IGF-1 DES (Des(1-3) Insulin-like Growth Factor-1)
CAS Number: N/A (Referenced as a natural splice variant; related CAS: 946870-92-4 for IGF analogs)
Molecular Formula: C₃₇₄H₅₉₈N₁₀₈O₁₂₁S
Molecular Weight: ~7.3 kDa (67 amino acids)
Amino Acid Sequence: Truncated human IGF-1 lacking the N-terminal tripeptide (Ala-Pro-Glu), corresponding to residues 4-70 of native IGF-1 with the sequence: H-Gly-Gly-Thr-Phe-Thr-Ser-Ile-Cys-Gly-Ala-Glu-Leu-Val-Asp-Ala-Leu-Gln-Phe-Val-Cys-Arg-Gly-Asp-Thr-Leu-Tyr-Tyr-Ser-Arg-Ser-Leu-Leu-Arg-Arg-Ala-Glu-Ile-Val-Asp-Asp-Leu-Pro-Pro-Thr-Glu-Val-Gly-Glu-Arg-Gly-Phe-Tyr-Gly-Ile-Ile-Ala-Leu-Leu-Lys-Ala-Glu-Gly-Tyr-Cys-Ala-Pro-Leu-Lys-Pro-Ala-Lys-Ser-Ala-NH₂
Purity: ≥98% (HPLC verified)
Formulation: Lyophilized powder (standard vials: 1mg, 5mg, 10mg)
🔬 Key Characteristics
IGF-1 DES (Des(1-3) IGF-1) is a naturally occurring splice variant of insulin-like growth factor-1, characterized by the deletion of the N-terminal three amino acids (Ala-Pro-Glu). This structural modification reduces binding affinity to insulin-like growth factor binding proteins (IGFBPs) by ~50-fold compared to native IGF-1, resulting in increased free bioavailability and potent activation of the IGF-1 receptor (IGF-1R). Originally identified in brain tissue, breast milk, and uterine epithelium, it exhibits enhanced metabolic stability and tissue penetration in preclinical models.
⚙️ Mechanism of Action
- IGF-1R Activation: Binds selectively to IGF-1R with high affinity, inducing receptor dimerization and autophosphorylation to activate downstream signaling cascades (PI3K/AKT and MAPK pathways).
- IGFBP Evasion: Truncation of the N-terminal domain disrupts IGFBP binding motifs, minimizing sequestration and prolonging half-life in biological fluids.
- Anabolic Signaling: Stimulates protein synthesis, cell cycle progression (G1→S phase transition), and inhibits apoptosis through AKT-mediated phosphorylation of FOXO transcription factors.
- Insulin-Like Activity: Exhibits weak cross-reactivity with insulin receptors, promoting glucose uptake in muscle and adipose tissue at high concentrations.
📊 Research Applications
- Cell Biology: In vitro studies of cell proliferation, differentiation, and survival (e.g., muscle satellite cells, neurons, osteoblasts).
- Oncology Research: Investigation of IGF-1R signaling in tumor growth and targeted therapy development (e.g., breast, prostate, and colorectal cancer models).
- Musculoskeletal Studies: Evaluation of muscle hypertrophy, bone regeneration, and sarcopenia interventions.
- Developmental Biology: Analysis of growth regulation in embryonic and fetal models, particularly in uterine and neural tissues.
💡 Product Features
- Bioactivity: Specific activity ≥5.0×10⁵ IU/mg (NBT-II cell proliferation assay), with ED₅₀ ≤0.5 ng/ml.
- Stability: Lyophilized form stable for 24 months at -20°C; reconstituted solutions (sterile PBS or 0.1% BSA) stable for 7 days at 4°C.
- Expression System: Recombinant production in E. coli or CHO cells, available with/without His-tag purification.
- Natural Occurrence: Mimics endogenously expressed splice variant, avoiding potential artifacts of synthetic analogs (e.g., IGF-1 LR3).
⚠️ Disclaimer
For Research Use Only: Not approved for human or veterinary clinical applications. Handling requires compliance with biosafety protocols for peptide research, including proper reconstitution, storage, and disposal of contaminated materials.



